Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicines in China and internationally. It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. The company was founded in 1993 and is based in Heze, China.
Research context
Shandong Buchang Pharmaceuticals Co., Ltd appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Shandong Buchang Pharmaceuticals Co., Ltd is currently in a long term downtrend where the price is trading 6.2% below its 200 day moving average.
From a valuation standpoint, the stock is 82.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.
Shandong Buchang Pharmaceuticals Co., Ltd's total revenue rose by 9.7% to $4B since the same quarter in the previous year.
Its net income has dropped by 10.2% to $494M since the same quarter in the previous year.
Finally, its free cash flow grew by 172.3% to $443M since the same quarter in the previous year.
Based on the above factors, Shandong Buchang Pharmaceuticals Co., Ltd gets an overall score of 3/5.